Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
atorvastatin (lipitor) (1 trial)
nitroglycerin (transderm-nitro) (2 trials)
Diabetic Neuropathies (Phase 2)
Hypertension (Phase 4)
Peripheral Nervous System Diseases (Phase 2)
Raynaud Disease (Phase 1)
Trials (3 total)
Trial APIs (2 total)